GALDERMA is the world's largest independent pharmaceutical company in the field of dermatology. It is a leader in the aesthetic medicine industry, having pioneered the production of the first hyaluronic acid that does not contain substances of animal origin. Galderma is also a distributor of botulinum toxin - in this area it became a pioneer in innovation, launching the first liquid botulinum toxin type A.
Galderma has the most diverse portfolio for injectable treatments on the market. These include products for various treatment categories, including skin regeneration, biostimulation, filling and lifting, which work well together in combination therapies.